These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 25887188

  • 1. Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma.
    Bolomsky A, Hose D, Schreder M, Seckinger A, Lipp S, Klein B, Heintel D, Ludwig H, Zojer N.
    J Hematol Oncol; 2015 Feb 08; 8():10. PubMed ID: 25887188
    [Abstract] [Full Text] [Related]

  • 2. [Expression of Insulin-Like Growth Factor Binding Protein 7 Gene in Multiple Myeloma Cell Line and Methylation Regulation].
    Liu WH, Ma YP.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun 08; 25(3):813-817. PubMed ID: 28641641
    [Abstract] [Full Text] [Related]

  • 3. Methylation patterns of IGFBP7 in colon cancer cell lines are associated with levels of gene expression.
    Lin J, Lai M, Huang Q, Ma Y, Cui J, Ruan W.
    J Pathol; 2007 May 08; 212(1):83-90. PubMed ID: 17334979
    [Abstract] [Full Text] [Related]

  • 4. Low expression of insulin-like growth factor binding protein 7 associated with poor prognosis in human glioma.
    Tian X, Zhang L, Sun L, Xue Y, Xie S.
    J Int Med Res; 2014 Jun 08; 42(3):651-8. PubMed ID: 24743871
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of IGF1-R overcomes IGFBP7-induced chemotherapy resistance in T-ALL.
    Bartram I, Erben U, Ortiz-Tanchez J, Blunert K, Schlee C, Neumann M, Heesch S, Baldus CD.
    BMC Cancer; 2015 Oct 08; 15():663. PubMed ID: 26450156
    [Abstract] [Full Text] [Related]

  • 6. IGFBP7 plays a potential tumor suppressor role against colorectal carcinogenesis with its expression associated with DNA hypomethylation of exon 1.
    Ruan WJ, Lin J, Xu EP, Xu FY, Ma Y, Deng H, Huang Q, Lv BJ, Hu H, Cui J, Di MJ, Dong JK, Lai MD.
    J Zhejiang Univ Sci B; 2006 Nov 08; 7(11):929-32. PubMed ID: 17048309
    [Abstract] [Full Text] [Related]

  • 7. IGFBP7 participates in the reciprocal interaction between acute lymphoblastic leukemia and BM stromal cells and in leukemia resistance to asparaginase.
    Laranjeira AB, de Vasconcellos JF, Sodek L, Spago MC, Fornazim MC, Tone LG, Brandalise SR, Nowill AE, Yunes JA.
    Leukemia; 2012 May 08; 26(5):1001-11. PubMed ID: 22005787
    [Abstract] [Full Text] [Related]

  • 8. Increased copy number of the interleukin-6 receptor gene is associated with adverse survival in multiple myeloma patients treated with autologous stem cell transplantation.
    Kim SY, Min HJ, Park HK, Oh B, Kim TY, She CJ, Hwang SM, Kim M, Kim HK, Kim I, Yoon SS, Park S, Kim BK, Lee JH, Lee DS, Korea Multiple Myeloma Working Party.
    Biol Blood Marrow Transplant; 2011 Jun 08; 17(6):810-20. PubMed ID: 21220034
    [Abstract] [Full Text] [Related]

  • 9. IGFBP7 promoter methylation and gene expression analysis in prostate cancer.
    Sullivan L, Murphy TM, Barrett C, Loftus B, Thornhill J, Lawler M, Hollywood D, Lynch T, Perry AS.
    J Urol; 2012 Oct 08; 188(4):1354-60. PubMed ID: 22906661
    [Abstract] [Full Text] [Related]

  • 10. IGFBP7 is a p53 target gene inactivated in human lung cancer by DNA hypermethylation.
    Chen Y, Cui T, Knösel T, Yang L, Zöller K, Petersen I.
    Lung Cancer; 2011 Jul 08; 73(1):38-44. PubMed ID: 21095038
    [Abstract] [Full Text] [Related]

  • 11. Effect of insulin-like growth factor-binding protein 7 on steroidogenesis in granulosa cells derived from equine chorionic gonadotropin-primed immature rat ovaries.
    Tamura K, Matsushita M, Endo A, Kutsukake M, Kogo H.
    Biol Reprod; 2007 Sep 08; 77(3):485-91. PubMed ID: 17522074
    [Abstract] [Full Text] [Related]

  • 12. Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome.
    Gambaro K, Quinn MC, Cáceres-Gorriti KY, Shapiro RS, Provencher D, Rahimi K, Mes-Masson AM, Tonin PN.
    BMC Cancer; 2015 Mar 17; 15():135. PubMed ID: 25886299
    [Abstract] [Full Text] [Related]

  • 13. Role of interleukin 16 in multiple myeloma.
    Atanackovic D, Hildebrandt Y, Templin J, Cao Y, Keller C, Panse J, Meyer S, Reinhard H, Bartels K, Lajmi N, Sezer O, Zander AR, Marx AH, Uhlig R, Zustin J, Bokemeyer C, Kröger N.
    J Natl Cancer Inst; 2012 Jul 03; 104(13):1005-20. PubMed ID: 22745469
    [Abstract] [Full Text] [Related]

  • 14. Glioblastoma-secreted factors induce IGFBP7 and angiogenesis by modulating Smad-2-dependent TGF-beta signaling.
    Pen A, Moreno MJ, Durocher Y, Deb-Rinker P, Stanimirovic DB.
    Oncogene; 2008 Nov 20; 27(54):6834-44. PubMed ID: 18711401
    [Abstract] [Full Text] [Related]

  • 15. Function and expression of insulin-like growth factor-binding protein 7 (IGFBP7) gene in childhood acute myeloid leukemia.
    Hu S, Chen R, Man X, Feng X, Cen J, Gu W, He H, Li J, Chai Y, Chen Z.
    Pediatr Hematol Oncol; 2011 May 20; 28(4):279-87. PubMed ID: 21413833
    [Abstract] [Full Text] [Related]

  • 16. Expression of IGFBP7 in acute leukemia is regulated by DNA methylation.
    Heesch S, Bartram I, Neumann M, Reins J, Mossner M, Schlee C, Stroux A, Haferlach T, Goekbuget N, Hoelzer D, Hofmann WK, Thiel E, Baldus CD.
    Cancer Sci; 2011 Jan 20; 102(1):253-9. PubMed ID: 21040219
    [Abstract] [Full Text] [Related]

  • 17. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y, Inokuchi M, Takagi Y, Otsuki S, Fujimori Y, Yanaka Y, Kobayashi K, Higuchi K, Kojima K, Kawano T.
    J Clin Pathol; 2015 Oct 20; 68(10):795-801. PubMed ID: 26043748
    [Abstract] [Full Text] [Related]

  • 18. IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype.
    Suzuki H, Igarashi S, Nojima M, Maruyama R, Yamamoto E, Kai M, Akashi H, Watanabe Y, Yamamoto H, Sasaki Y, Itoh F, Imai K, Sugai T, Shen L, Issa JP, Shinomura Y, Tokino T, Toyota M.
    Carcinogenesis; 2010 Mar 20; 31(3):342-9. PubMed ID: 19638426
    [Abstract] [Full Text] [Related]

  • 19. IGFBP7 downregulation is associated with tumor progression and clinical outcome in hepatocellular carcinoma.
    Tomimaru Y, Eguchi H, Wada H, Kobayashi S, Marubashi S, Tanemura M, Umeshita K, Kim T, Wakasa K, Doki Y, Mori M, Nagano H.
    Int J Cancer; 2012 Jan 15; 130(2):319-27. PubMed ID: 21328580
    [Abstract] [Full Text] [Related]

  • 20. Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load.
    Neben K, Jauch A, Hielscher T, Hillengass J, Lehners N, Seckinger A, Granzow M, Raab MS, Ho AD, Goldschmidt H, Hose D.
    J Clin Oncol; 2013 Dec 01; 31(34):4325-32. PubMed ID: 24145347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.